Vimarsana
Biggest News Aggregation in the World

Executive Steering News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Executive Steering. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Executive Steering Today - Breaking & Trending Today

Diagnosis: Checking The Pulse Of Florida Health Care News And Policy - Vimarsana News

Diagnosis: Checking The Pulse Of Florida Health Care News And Policy

Published: January 4, 2024

It's time again to check the pulse — of Florida's health care policy and politics.

Source: southfloridareporter.com
Related Topics:
United StatesDaytona BeachWest Palm BeachUniversity Of South FloridaUniversity Of MississippiUniversity Of Central FloridaSankt PeterburgBroward CountyHillsborough CountyBoca Raton SenAshley MoodyMatthew PinzurTina PolskyKathleen PassidomoSara ClementsAndrew MulcahyAngus JamesonKristina HeathColin HackleySean StaffordDonald TrumpStacey BrandtJason WeidaKristin HeathMark Mckenney
BioCardia Announces Interim Efficacy Results in Phase III Pivotal CardiAMP Cell Therapy Heart Failure Trial - Vimarsana News

BioCardia Announces Interim Efficacy Results in Phase III Pivotal CardiAMP Cell Therapy Heart Failure Trial

Published: September 5, 2023

SUNNYVALE, Calif., Sept. 05, 2023 (GLOBE NEWSWIRE) -- BioCardia®, Inc. [Nasdaq: BCDA], a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary disease, today announced it has finalized external review of interim data and evaluated interim efficacy results for the ongoing Phase III pivotal trial of CardiAMP® Cell Therapy for Heart Failure (CardiAMP HF, clinicaltrials.gov Identifier: NCT02438306), for which the FDA granted Breakthrough Designation fo

Source: yahoo.com
Related Topics:
United StatesUniversity Of WisconsinPeter AltmanCarl PepineMiranda PetoDavid McclungStatistical Data Analysis CenterExchange Commission OnUniversity Of Florida At GainesvilleNational Principal InvestigatorBiocardia IncNational Principal InvestigatorsMaryland Stem Cell Research FundCardiamp Cell Therapy ProgramCell TherapyHeart FailureBreakthrough DesignationSix Minute Walk TestCo National Principal InvestigatorsAmish RavalCo National Principal InvestigatorBiocardia PresidentPrincipal InvestigatorsExecutive SteeringUpcoming Milestones
BioCardia Announces Interim Efficacy Results in Phase III Pivotal CardiAMP Cell Therapy Heart Failure Trial - BioCardia (NASDAQ:BCDA) - Vimarsana News

BioCardia Announces Interim Efficacy Results in Phase III Pivotal CardiAMP Cell Therapy Heart Failure Trial - BioCardia (NASDAQ:BCDA)

Published: September 5, 2023

SUNNYVALE, Calif., Sept. 05, 2023 (GLOBE NEWSWIRE) -- BioCardia®, Inc. (NASDAQ:BCDA), a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary disease, today

Source: benzinga.com
Related Topics:
United StatesUniversity Of WisconsinCarl PepineDavid McclungMiranda PetoPeter AltmanCardiamp Cell Therapy ProgramNational Principal InvestigatorsUniversity Of Florida At GainesvilleBiocardia IncNational Principal InvestigatorStatistical Data Analysis CenterExchange Commission OnMaryland Stem Cell Research FundCell TherapyHeart FailureBreakthrough DesignationSix Minute Walk TestCo National Principal InvestigatorsAmish RavalCo National Principal InvestigatorBiocardia PresidentPrincipal InvestigatorsExecutive SteeringUpcoming Milestones
Investegate |Clariant International Ltd Announcements | Clariant International Ltd: Clariant's shareholders approve all agenda items - Vimarsana News

Investegate |Clariant International Ltd Announcements | Clariant International Ltd: Clariant's shareholders approve all agenda items

Published: April 4, 2023

Investegate announcements from Clariant International Ltd, Clariant’s shareholders approve all agenda items

Source: investegate.co.uk
Related Topics:
Switzerland GeneralConrad KeijzerJochen DubielMaria IvekThijs BouwensBalthasar SettelenOanne MaierAndreas SchwarzwEllese CaruanaArticles Of AssociationSteering CommitteeCompensation CommitteeSteering Committee ExecutiveFinancial StatementsConsolidated Financial StatementsAnnual General MeetingIntegrated ReportExecutive SteeringExecutive CommitteeAnnual GeneralChief Executive OfficerSwiss CodeGeneral MeetingExecutive Steering CommitteeBusiness Units Care Chemicals
Clariant International Ltd: Clariant's shareholders approve all agenda items - Vimarsana News

Clariant International Ltd: Clariant's shareholders approve all agenda items

Published: April 4, 2023

Integrated Report, Financial Statements and Consolidated Financial Statements of Clariant for the fiscal year 2022 approvedIncreased distribution of CHF 0.42 per share confirmedProposed amendments to the

Source: finanznachrichten.de
Related Topics:
Switzerland GeneralBalthasar SettelenAndreas SchwarzwEllese CaruanaOanne MaierJochen DubielConrad KeijzerMaria IvekThijs BouwensCompensation CommitteeSteering Committee ExecutiveSteering CommitteeArticles Of AssociationIntegrated ReportFinancial StatementsConsolidated Financial StatementsAnnual General MeetingExecutive SteeringExecutive CommitteeAnnual GeneralChief Executive OfficerSwiss CodeGeneral MeetingExecutive Steering CommitteeBusiness Units Care Chemicals